"10.1371_journal.pone.0025581","plos one","2011-09-27T00:00:00Z","Marine Germain; Noémie Saut; Nicolas Greliche; Christian Dina; Jean-Charles Lambert; Claire Perret; William Cohen; Tiphaine Oudot-Mellakh; Guillemette Antoni; Marie-Christine Alessi; Diana Zelenika; François Cambien; Laurence Tiret; Marion Bertrand; Anne-Marie Dupuy; Luc Letenneur; Mark Lathrop; Joseph Emmerich; Philippe Amouyel; David-Alexandre Trégouët; Pierre-Emmanuel Morange","INSERM UMR_S 937; ICAN Institute, Université Pierre et Marie Curie, Paris 6; Paris, France; INSERM, UMR_S 626, Marseille, France; Université de la Méditerranée, Marseille, France; INSERM UMR_S 915; CNRS ERL3147; Institut du Thorax; Nantes, France; INSERM U744, Lille, France; Institut Pasteur de Lille, Lille, France Université de Lille Nord de France, Lille, France; Commissariat à l'Energie Atomique, Institut de Génomique, Centre National de Génotypage, Evry, France; INSERM UMR_S 708, Université Pierre et Marie Curie (UPMC, Paris 6), Paris, France; INSERM U888, Hôpital La Colombière, Montpellier, France; INSERM, U897, Bordeaux, France; Université Victor Segalen, Bordeaux, France; INSERM U765, médecine vasculaire - HTA, hôpital européen Georges-Pompidou, Université Paris-Descartes, Paris, France; CHRU de Lille, Lille, France","Conceived and designed the experiments: D-AT P-EM PA ML. Performed the experiments: NS CP DZ. Analyzed the data: MG NG TO-M GA D-AT CD J-CL FC LT. Contributed reagents/materials/analysis tools: P-EM PA ML LL A-MD MB JE NS M-CA WC. Wrote the paper: MG D-AT P-EM.","The authors have read the journal's policy and have the following conflicts. Funding was received from Sanofi-Synthélabo. The Lille Génopôle received an unconditional grant from Eisai. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","09","Marine Germain","MG",21,TRUE,4,3,9,3,TRUE,TRUE,FALSE,0,NA,FALSE
